IM Cannabis Corp., a medical marijuana company operating in Israel and Germany, said it has regained compliance with the minimum-bid price requirement to list on the Nasdaq stock exchange.
The company said in a Monday news release that it received notification July 26 that it’s “now in compliance with all applicable listing standards” to be listed and traded on the Nasdaq.
ADVERTISEMENT
The Nasdaq warned IM Cannabis (IMC) on Aug. 1, 2023, that its minimum-bid price was less than the required $1-per-share minimum for 30 consecutive business days, according to the release.
Then, on Jan. 31, the exchange gave IMC a 180-calendar-day extension – until July 29 – to regain compliance.
Now, according to the Nasdaq, IMC’s closing price has met or surpassed
Read full article on Marijuana Business Daily
